Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023

SELL
$183.43 - $232.67 $2,751 - $3,490
-15 Reduced 0.58%
2,576 $482,000
Q4 2022

Feb 09, 2023

SELL
$187.24 - $242.74 $5,055 - $6,553
-27 Reduced 1.03%
2,591 $523,000
Q3 2022

Nov 02, 2022

SELL
$177.23 - $227.44 $4,253 - $5,458
-24 Reduced 0.91%
2,618 $499,000
Q2 2022

Jul 21, 2022

SELL
$181.58 - $368.0 $4,539 - $9,200
-25 Reduced 0.94%
2,642 $487,000
Q1 2022

May 12, 2022

BUY
$303.87 - $423.8 $12,762 - $17,799
42 Added 1.6%
2,667 $932,000
Q4 2021

Feb 09, 2022

SELL
$347.28 - $421.83 $26,045 - $31,637
-75 Reduced 2.78%
2,625 $999,000
Q3 2021

Nov 08, 2021

BUY
$405.61 - $524.84 $4,056 - $5,248
10 Added 0.37%
2,700 $1.1 Million
Q2 2021

Aug 13, 2021

SELL
$372.84 - $481.5 $891,460 - $1.15 Million
-2,391 Reduced 47.06%
2,690 $1.27 Million
Q4 2020

Jan 29, 2021

SELL
$292.7 - $370.96 $2,927 - $3,709
-10 Reduced 0.2%
5,081 $1.88 Million
Q3 2020

Oct 30, 2020

SELL
$268.51 - $400.74 $1,879 - $2,805
-7 Reduced 0.14%
5,091 $1.57 Million
Q2 2020

Jul 28, 2020

SELL
$256.46 - $373.01 $26,158 - $38,047
-102 Reduced 1.96%
5,098 $1.89 Million
Q4 2019

Jan 29, 2020

SELL
$288.29 - $335.49 $1,729 - $2,012
-6 Reduced 0.12%
5,200 $1.73 Million
Q3 2019

Oct 21, 2019

SELL
$266.84 - $378.23 $800 - $1,134
-3 Reduced 0.06%
5,206 $1.58 Million
Q2 2019

Jul 25, 2019

SELL
$300.59 - $368.15 $3,907 - $4,785
-13 Reduced 0.25%
5,209 $1.92 Million
Q3 2018

Oct 25, 2018

BUY
$279.04 - $367.06 $334,289 - $439,737
1,198 Added 29.77%
5,222 $1.92 Million
Q2 2018

Jul 26, 2018

BUY
$228.17 - $292.07 $8,442 - $10,806
37 Added 0.93%
4,024 $1.12 Million
Q1 2018

May 04, 2018

SELL
$209.54 - $253.91 $256,267 - $310,531
-1,223 Reduced 23.47%
3,987 $943,000
Q3 2017

Oct 31, 2017

BUY
$172.3 - $213.93 $897,683 - $1.11 Million
5,210
5,210 $1.04 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Middleton & CO Inc Portfolio

Follow Middleton & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Middleton & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Middleton & CO Inc with notifications on news.